標題: Effects of gonadotropins (Gonal-F and Puregon) on human endometrial cell proliferation in vitro
作者: Chang, Chi-Chen
Hsieh, Yao-Yuan
Hsu, Kung-Hao
Lin, Chih-Sheng
生物科技學系
Department of Biological Science and Technology
關鍵字: Endometrium;Gonadotropin;Gonal-F;IVF;Puregon
公開日期: 1-Mar-2011
摘要: Condensation: Both Gonal-F and Puregon, especially in their high-dosage administration, might inhibit the endometrial cell proliferation in the initial 48-hour culture. After 72-hour culture, Gonal-F persisted the inhibition of the endometrial growth, whereas Puregon reversed its effect to enhance endometrial growth. Objectives: Endometrial proliferation or regeneration during menstrual cycle is regulated by sexual hormones. However, the effect of gonadotropins on the endometrial cell growth remains obscure. Herein, we aimed to investigate the effects of recombinant follicle-stimulating hormones (r-FSHs) (Gonal-F and Puregon) on the proliferation of human endometrial cells in vitro. Materials and Methods: Human endometrial cells (RL95-2 cells) were obtained commercially and cultured in the serum-containing media in the presence of r-FSHs (Gonal-F and Puregon at concentrations of 0 mIU/mL, 200 mIU/mL, 400 mIU/mL, and 600 mIU/mL) up to 72 hours. According to the gonadotropin concentrations, all cultured endometrial cells were divided into four groups: (1) 0 mIU/mL (control); (2) 200 mIU/mL; (3) 400 mIU/mL; and (4) 600 mIU/mL. After 72-hour culture, endometrial cell proliferations were assessed overnight by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The influences of different r-FSH agents and dosages on endometrial cell proliferation in each group were evaluated and compared. Results: In the four Gonal-F groups, the cell absorption (control and 200 mIU/mL, 400 mIU/mL, and 600 mIU/mL Gonal-F) after 24/48/72-hour cultures were as follows: (1) 0.57/0.7/0.82; (2) 0.56/0.66/0.78; (3) 0.55/0.64/0.77: and (4) 0.51/0.61/0.78. After 48 hours, higher dosage of Gonal-F appeared to significantly inhibit the endometrial cell proliferation. After 72-hour culture, all three dosages of Gonal-F appeared to inhibit the endometrial cell proliferation similarly. In Puregon groups, the cell absorptions were as follows: (1) 0.62/0.53/0.62; (2) 0.61/0.5/0.66; (3) 0.61/0.49/0.66; and (4) 0.64/0.49/0.66. Puregon administration displayed initial inhibition and subsequent stimulation effects on the endometrial cells. Conclusions: Both Gonal-F and Puregon, especially in their high-dosage administration, appeared to inhibit the endometrial cell proliferation in the initial 48-hour culture. After 72-hour culture, Gonal-F persisted the inhibition of the endometrium, whereas Puregon reversed its effect by enhancing the endometrial growth. The differences might be because of the different formulations or molecular structures existing between alpha and beta follitropins. Copyright (C) 2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
URI: http://dx.doi.org/10.1016/j.tjog.2009.08.003
http://hdl.handle.net/11536/9164
ISSN: 1028-4559
DOI: 10.1016/j.tjog.2009.08.003
期刊: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY
Volume: 50
Issue: 1
起始頁: 42
結束頁: 47
Appears in Collections:Articles


Files in This Item:

  1. 000290188000010.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.